Monthly Archives: April 2015

Heated Chemo Peritoneal Mesothelioma

Heated Chemo Confirmed Effective Against Peritoneal Mesothelioma

Carcinomatosis is a term used by mesothelioma doctors to mean that the disease’s cells are spreading within your body. When they speak of peritoneal carcinomatosis, it means mesothelioma tumors are popping up along the lining of your abdomen. One of the treatments mesothelioma doctors have developed to combat peritoneal carcinomatosis is hyperthermic intraperitoneal chemotherapy. Researchers

Continue Reading →
Mesothelioma Prognostic Index

New Tool May Help Doctors Better Predict Mesothelioma Survival

You go to the mesothelioma clinic because you’re showing symptoms of mesothelioma. The doctor runs some tests on you and, sure enough, you learn you’ve got mesothelioma. One of the first questions you’re almost certain to ask after receiving your mesothelioma diagnosis is: “How long have I got to live?” The doctor may or may

Continue Reading →
mesothelioma orphan drug

Immunotherapy Agent for Mesothelioma Wins Orphan Drug Status

Novel immunotherapy agent CRS-207 recently won orphan drug status from the U.S. Food and Drug Administration (FDA), which makes it more likely you’ll someday soon see it marketed specifically for the treatment of mesothelioma. The significance of orphan drug status is that it paves the way for the makers of therapeutic products such as CRS-207

Continue Reading →
Multimodality Attacks Against Mesothelioma

Multimodality Attacks Against Mesothelioma Yield Better Results

Researchers in Europe have found that malignant pleural mesothelioma attacked with a combination of radical surgery, povidone-iodine hyperthermic pleural lavage, preventive radiotherapy, and systemic chemotherapy can be a safe and effective strategy for extending survival. Among patients treated with these four modalities all at once, median survival was 32 months. Notably, an average of 23

Continue Reading →
Artificial Antibodies mesothelioma

Artificial Antibodies May Help Immune System Beat Mesothelioma

Your body’s immune system let you down by allowing mesothelioma to get started and establish a foothold on the lining of your lungs, abdomen or heart. Your immune system let you down again by not counterattacking forcefully enough to eradicate those vanguard mesothelioma cells before they could multiply and spread like wildfire. Those failures might

Continue Reading →
Higher Doses of Tremelimumab mesothelioma

Higher Doses of Tremelimumab Better at Halting Mesothelioma

The targeted mesothelioma therapeutic agent tremelimumab appears to work, but to achieve best results it turns out you have to take more of it for a longer stretch than researchers envisioned. Fortunately, you’ll probably be able to tolerate the extra amount, according to research from Italy that appeared in the April 2015 issue of the

Continue Reading →
gene sequence mesothelioma

Genomic Analysis of Mesothelioma Patients May Lead to Better Care

Mesothelioma treatments tend to be hit or miss. A therapy that works well for you might not work at all for the next guy in line, even though both your cases are similar, physiologically and medically. Mesothelioma doctors have never really understood why this is so. However, new research out of British Columbia appears to

Continue Reading →
Artificial Sugar Mesothelioma

Artificial Sugar May One Day Be Mesothelioma’s Undoing

This is sweet. Saccharin — the artificial sugar that once was feared to be carcinogenic — may prove itself a magic ingredient that stops the growth of mesothelioma. Researchers at the University of Florida Health Sciences Center discovered that saccharin interferes with the processes that allow aggressive cancers to spread. The researchers haven’t yet tested saccharin against

Continue Reading →
Mild Electric Pulses Kill Mesothelioma

Mesothelioma Cells: Can Mild Electric Pulses Kill Them?

A therapy designed to promote the death of mesothelioma cells by subjecting them to low-intensity, alternating electric fields during chemotherapy is being clinically tested in Europe. The company that developed the therapy, Novocure, announced in February that it had begun enrolling mesothelioma patients into a Phase II clinical trial to test the safety and efficacy

Continue Reading →